Encompass Health Corporation Financial Ratios — EHC Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	208.7	134.22	75.6	54.22
Return on Assets (%)	8.99	7.88	13.05	7.5	4.58	5.33	5.68	5.82	6.37	4.54	6.19	4.34	6	7.21	8.31
Return on Capital (%)	-25.08	-24.92	-68.48	233.83	17.65	15.86	15.99	15.9	14.29	9.68	11.2	8.05	9.23	10.25	10.32
Return on Invested Capital (%)	19.03	14.81	21.94	13.42	10.27	10.62	11.24	12.22	11.44	7.73	9.21	9.13	11.35	12.81	14.54
Gross Margin (%)	94.88	46.01	46.82	46.36	42.24	41.64	41.14	41.25	40.48	95.21	95.41	40.32	41.3	41.56	95.71
EBITDA Margin (%)	22.58	23.23	24.63	24.15	22.27	22.55	21.29	20.6	19.79	20.56	21.89	20.09	20.95	21.66	23.27
Operating Margin (%)	18.65	19.36	20.42	19.61	17.79	17.81	16.59	15.94	15.04	14.87	16.42	14.49	15.24	16.09	17.74
Incremental Operating Margin (%)	32	30.47	40.43	5.43	11.94	17.95	0.22	8.86	3.33	15.61	28.76	-8.75	22.45	23.2	33.56
Pretax Margin (%)	12.11	15.93	17.59	16.3	12.7	13.23	12.68	11.53	12.21	9.9	12.58	10.37	12.65	13.95	16.06
Profit Margin (%)	10.4	8.67	14.4	9.35	5.88	6.8	6.93	6.83	7.79	7.97	10.27	6.23	7.33	8.48	9.54
Net Income to Common Margin (%)	9.11	7.55	13.47	9.08	5.83	6.8	6.93	6.83	7.79	7.97	10.27	6.23	7.33	8.48	9.54
Effective Tax Rate (%)	15.27	31.94	3.21	28.61	35.87	34	29.37	24.11	20.61	21.17	20.18	22.2	21.77	20.04	20.24
Dvd Payout Ratio (%)	- -	0.27	4.22	19.96	23.49	21.56	21.29	22.04	20.37	30.82	22.08	22.22	10.31	8.48	7.46
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	162.33	120.39	69.18	50.18

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	1,255	1,254	1,518	2,111	3,172	3,016	2,578	2,514	3,347	3,543	3,481	2,992	2,933	2,714	2,714
ST Debt	19	14	12	21	37	37	32	36	80	83	61	51	49	165	70
LT Debt	1,236	1,240	1,505	2,090	3,135	2,979	2,545	2,479	3,267	3,460	3,420	2,942	2,884	2,549	2,644
Total Debt/EBITDA	2.77	2.53	2.74	3.68	4.57	3.67	3.09	2.85	3.67	4.83	3.96	3.42	2.92	2.33	1.97
Net Debt/EBITDA	2.7	2.26	2.63	3.57	4.48	3.62	3.03	2.77	3.26	4.18	3.67	3.14	2.63	2.07	1.75
Total Debt/EBIT	3.35	3.03	3.31	4.53	5.72	4.65	3.97	3.69	4.83	6.68	5.28	4.75	4.01	3.14	2.58
Net Debt/EBIT	3.27	2.71	3.17	4.39	5.61	4.59	3.89	3.59	4.29	5.78	4.9	4.36	3.61	2.79	2.3
EBITDA to Interest Expense	3.79	5.27	5.51	5.25	4.86	4.77	5.4	5.98	5.71	3.99	5.35	4.97	7.01	8.47	11.21
EBITDA-CapEx/Interest Expense	2.88	3.57	3.36	3.53	3.76	3.59	3.91	4.22	3.26	1.84	1.99	1.59	2.94	3.8	5.23
EBIT to Interest Expense	3.13	4.39	4.57	4.26	3.88	3.77	4.21	4.63	4.34	2.89	4.01	3.59	5.1	6.29	8.55
Interest Expense	119	94	100	109	143	172	154	147	160	184	164	176	144	137	123
Common Equity/Total Assets	-114.86	-99.98	-82.86	-55.43	-36.8	-30.91	-24.16	-17.08	-8.64	-3.74	2.08	2.07	6.68	12.21	18.2
Long-Term Debt/Equity (%)	209.81	164.68	261.59	262.15	348.15	279.22	157.48	136.28	169.04	172.87	142.55	157.98	125.54	89.46	80.71
Long-Term Debt/Capital (%)	-140.11	-175.05	-427.86	375.09	177.54	156.79	136.38	114.1	96.04	93.12	83.17	80.35	72.27	59.36	54.6
Long-Term Debt/Total Assets (%)	54.41	51.15	59.39	61.69	68.06	63.63	52.33	47.9	53.73	53.68	49.82	52.19	47.26	39.01	37.29
Total Debt/Equity (%)	213.02	166.49	263.73	264.76	352.23	282.7	159.48	138.25	173.17	177.02	145.11	160.71	127.67	95.25	82.85
Total Debt/Capital (%)	-142.26	-176.97	-431.35	378.83	179.63	158.74	138.11	115.75	98.38	95.36	84.66	81.74	73.5	63.2	56.05
Total Debt/Total Assets (%)	55.24	51.71	59.88	62.31	68.85	64.43	52.99	48.59	55.04	54.97	50.71	53.09	48.06	41.53	38.28
Net Debt to Equity	207.91	148.85	252.52	256.4	345.39	278.9	156.12	134.45	153.56	153.12	134.58	147.44	115.07	84.67	73.83
Net Debt/Capital (%)	-134.26	-133.24	-349.03	416.73	182.51	160.02	139.25	116.27	89.74	87.78	79.47	75.44	67.42	57.32	50.71
EBITDA	453	496	554	573	694	821	833	881	911	733	879	874	1,006	1,164	1,381
EBITDA-CapEx	344	336	337	386	537	618	604	621	520	337	327	280	423	522	645
Operating Income (Loss)	374	413	459	466	554	649	649	682	692	530	659	630	732	864	1,053

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.14	0.44	0.21	0.18	0.14	0.09	0.11	0.1	0.13	0.31	0.07	0.04	0.11	0.1	0.09
Current Ratio	1.57	2.12	1.86	1.88	1.4	1.38	1.36	0.98	1.05	1.32	1.23	1.25	1.28	1.05	1.08
Quick Ratio	0.86	1.27	1.05	1.07	1.11	1.02	1.02	0.8	0.83	1.11	0.75	0.97	1.04	0.81	0.83
CFO/Avg Current Liab	1.02	1.34	1.54	1.32	1.27	1.42	1.33	1.28	0.91	0.98	0.98	1.07	1.38	1.34	1.4
Common Equity/Total Assets	-114.86	-99.98	-82.86	-55.43	-36.8	-30.91	-24.16	-17.08	-8.64	-3.74	2.08	2.07	6.68	12.21	18.2
Long-Term Debt/Equity (%)	209.81	164.68	261.59	262.15	348.15	279.22	157.48	136.28	169.04	172.87	142.55	157.98	125.54	89.46	80.71
Long-Term Debt/Capital (%)	-140.11	-175.05	-427.86	375.09	177.54	156.79	136.38	114.1	96.04	93.12	83.17	80.35	72.27	59.36	54.6
Long-Term Debt/Total Assets (%)	54.41	51.15	59.39	61.69	68.06	63.63	52.33	47.9	53.73	53.68	49.82	52.19	47.26	39.01	37.29
Total Debt/Equity (%)	213.02	166.49	263.73	264.76	352.23	282.7	159.48	138.25	173.17	177.02	145.11	160.71	127.67	95.25	82.85
Total Debt/Capital (%)	-142.26	-176.97	-431.35	378.83	179.63	158.74	138.11	115.75	98.38	95.36	84.66	81.74	73.5	63.2	56.05
Total Debt/Total Assets (%)	55.24	51.71	59.88	62.31	68.85	64.43	52.99	48.59	55.04	54.97	50.71	53.09	48.06	41.53	38.28
CFO/Total Liabilities	20.37	24.62	24.01	17.17	13.55	17.71	20.27	22.72	15.32	15.86	16.03	18.7	22.36	27.21	30.82
CFO/CapEx	3.14	2.58	2.17	2.37	3.21	3.16	2.87	2.93	1.62	1.78	1.3	1.19	1.46	1.56	1.6
Altman's Z-Score	0.36	0.84	1.29	1.45	1.61	2.18	2.54	2.86	2.66	2.3	1.9	2.6	2.81	3.4	3.75

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	8.96	9.04	8.79	8.12	8.49	8.53	8.55	9.1	9.46	6.61	7.38	8.26	8.36	8.88	9.75
Days Sales Outstanding	40.73	40.36	41.51	44.97	42.98	42.8	42.71	40.1	38.59	55.21	49.48	44.18	43.65	41.11	37.45
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	2.18	25.42	22.3	22.09	31.3	32.73	31.41	29.84	29.7	1.63	1.48	19.45	18.61	18.42	1.46
Accounts Payable Turnover Days	167.41	14.36	16.37	16.52	11.66	11.15	11.62	12.23	12.29	223.7	246.7	18.77	19.61	19.82	250.51
Cash Conversion Cycle	-126.68	26	25.14	28.44	31.31	31.65	31.09	27.87	26.3	-168.48	-197.22	25.41	24.04	21.29	-213.06
Inventory to Cash Days	40.73	40.36	41.51	44.97	42.98	42.8	42.71	40.1	38.59	55.21	49.48	44.18	43.65	41.11	37.45
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	1,311	1,587	2,334	2,654	2,475	2,922	3,681	4,803	5,398	6,483	5,137	5,933	6,639	9,226	10,667
- Cash & Cash Equivalents	30	133	64	67	62	40	54	69	95	224	49	22	69	85	72
+ Preferred Equity and Hybrid Capital	387	342	93	93	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	85	120	138	231	289	331	464	542	580	414	488	552	650	782	838
+ Total Debt	1,255	1,254	1,518	2,111	3,172	3,016	2,578	2,514	3,347	3,543	3,481	2,992	2,933	2,714	2,714
Enterprise Value	2,992	3,170	4,018	5,023	5,873	6,229	6,669	7,790	9,230	10,216	9,057	9,455	10,152	12,636	14,146
Total Capital	-882	-708	-352	557	1,766	1,900	1,866	2,172	3,402	3,716	4,112	3,661	3,990	4,294	4,842
Total Debt/Capital (%)	-142.26	-176.97	-431.35	378.83	179.63	158.74	138.11	115.75	98.38	95.36	84.66	81.74	73.5	63.2	56.05
Total Debt / EV	0.42	0.4	0.38	0.42	0.54	0.48	0.39	0.32	0.36	0.35	0.38	0.32	0.29	0.21	0.19
EV/Sales	1.49	1.48	1.79	2.12	1.89	1.71	1.7	1.82	2	2.86	2.26	2.17	2.11	2.35	2.38
EV/EBITDA	6.61	6.39	7.26	8.76	8.46	7.58	8	8.84	10.13	13.93	10.3	10.82	10.09	10.86	10.24
EV/EBIT	8	7.67	8.76	10.79	10.6	9.6	10.27	11.43	13.33	19.26	13.74	15	13.87	14.62	13.43
EV/Cash Flow to Firm	6.74	6.67	7.08	9.61	9.89	8.26	8.69	8.91	12.11	12.03	10.69	11.22	10.54	11.36	11.11
EV/Free Cash Flow to Firm	5.41	4.99	5.12	7.07	7.83	6.51	6.69	6.87	8	8.2	6.47	6.58	6.57	7.2	7.04
Diluted Market Cap	1,534	1,814	2,705	3,079	2,796	3,263	3,901	4,896	5,475	6,562	5,199	6,005	6,759	9,438	10,848
Diluted Enterprise Value	3,231	3,397	4,388	5,448	6,195	6,570	6,889	7,883	9,307	10,295	9,119	9,527	10,272	12,849	14,327
EV per Share	32.07	33.51	45.6	57.87	65.7	69.91	71.17	79.57	94.19	103.61	91.48	95.32	102.03	126.49	140.76
TTM Sales	2,006	2,135	2,247	2,374	3,116	3,643	3,914	4,277	4,605	3,566	4,015	4,349	4,801	5,373	5,935
TTM EBITDA	453	496	554	573	694	821	833	881	911	733	879	874	1,006	1,164	1,381
TTM Operating Income	374	413	459	466	554	649	649	682	692	530	659	630	732	864	1,053
TTM Cash Flow to Firm	444	476	567	523	594	754	767	874	762	850	847	842	963	1,113	1,274
TTM Free Cash Flow to Firm	553	635	784	711	750	957	997	1,134	1,153	1,246	1,399	1,437	1,546	1,755	2,010

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	3.4	3.18	3.94	4.87	4.25	3.87	4.39	4.79	5.33	5.96	4.1	4.62	4.71	5.74	5.67
EV/EBIT	8	7.67	8.76	10.79	10.6	9.6	10.27	11.43	13.33	19.26	13.74	15	13.87	14.62	13.43
Enterprise Value	2,992	3,170	4,018	5,023	5,873	6,229	6,669	7,790	9,230	10,216	9,057	9,455	10,152	12,636	14,146
Low Price	10.85	13.16	17.12	23.71	25.88	24.06	30.41	39.09	45.11	38.17	44.77	42.16	51.15	65.99	87.85
EV/Sales	1.49	1.48	1.79	2.12	1.89	1.71	1.7	1.82	2	2.86	2.26	2.17	2.11	2.35	2.38
EV/EBITDA	6.61	6.39	7.26	8.76	8.46	7.58	8	8.84	10.13	13.93	10.3	10.82	10.09	10.86	10.24
Price/Earnings	7.17	9.85	7.71	12.31	13.63	11.8	13.58	16.43	15.05	22.81	12.46	21.89	18.86	20.25	18.84
Price/Earnings Average	8.85	9.99	6.94	11.64	16.38	11.14	12.36	17.64	13.91	19.22	14.77	19.02	17.99	18.96	19.86
Price/Earnings High	11.57	11.67	8.57	13.57	18.94	12.41	13.85	21.96	15.84	24.03	17.12	21.93	20.37	22.92	22.72
Price/Earnings Low	5.54	7.73	4.98	9.54	12.75	8.66	10.51	13.09	12.32	13.24	10.75	15.43	14.46	14.47	15.59
Price/Book Value	-0.5	-0.65	-1.11	-1.41	-1.46	-2.02	-3.13	-5.43	-10.27	-26.88	35.95	50.8	16.28	11.56	8.27
Price/Book Value Average	-0.62	-0.66	-1	-1.34	-1.75	-1.91	-2.85	-5.83	-9.5	-22.65	42.6	44.13	15.53	10.83	8.71
Price/Book Value High	-0.81	-0.78	-1.23	-1.56	-2.03	-2.12	-3.2	-7.26	-10.82	-28.31	49.4	50.88	17.59	13.09	9.97
Price/Book Value Low	-0.39	-0.51	-0.72	-1.1	-1.37	-1.48	-2.42	-4.33	-8.41	-15.6	31.02	35.81	12.48	8.26	6.84
Price/Tangible Book Value	-4.72	-15.91	-37.1	-3.87	-1.76	-2.3	-4.85	-6.62	-6.36	-8.66	5.12	18.75	9	7.29	6.47
Price/Tangible Book Value Average	-5.82	-16.12	-33.4	-3.66	-2.11	-2.17	-4.41	-7.11	-5.88	-7.3	6.07	16.29	8.58	6.82	6.82
Price/Tangible Book Value High	-7.61	-18.83	-41.22	-4.27	-2.44	-2.42	-4.95	-8.85	-6.7	-9.12	7.03	18.78	9.72	8.25	7.8
Price/Tangible Book Value Low	-3.64	-12.47	-23.98	-3	-1.64	-1.69	-3.75	-5.27	-5.21	-5.03	4.42	13.22	6.9	5.21	5.35
Price/Sales	0.65	0.74	1.04	1.12	0.79	0.8	0.94	1.12	1.17	1.82	1.28	1.36	1.38	1.72	1.8
Price/Sales Average	0.81	0.75	0.93	1.06	0.95	0.76	0.86	1.21	1.08	1.53	1.52	1.19	1.32	1.61	1.89
Price/Sales High	1.05	0.88	1.15	1.23	1.1	0.84	0.96	1.5	1.23	1.91	1.76	1.37	1.49	1.94	2.17
Price/Sales Low	0.5	0.58	0.67	0.87	0.74	0.59	0.73	0.89	0.96	1.06	1.1	0.96	1.06	1.23	1.49
Price/Cash Flow	3.83	3.86	4.96	5.97	4.93	4.56	5.59	6.3	8.5	9.2	7.18	8.41	7.8	9.2	9.07
Price/Cash Flow Average	4.72	3.91	4.47	5.64	5.92	4.31	5.09	6.76	7.85	7.75	8.51	7.3	7.44	8.61	9.57
Price/Cash Flow High	6.17	4.57	5.51	6.58	6.85	4.8	5.7	8.42	8.95	9.69	9.86	8.42	8.43	10.42	10.94
Price/Cash Flow Low	2.95	3.03	3.21	4.63	4.61	3.35	4.33	5.02	6.96	5.34	6.19	5.93	5.98	6.57	7.51
Price/Free Cash Flow Average	4.19	3.22	3.54	4.6	5.1	3.65	4	5.14	4.93	5.02	4.86	4.01	4.5	5.37	5.98
Price/Free Cash Flow High	5.48	3.76	4.38	5.37	5.9	4.07	4.48	6.4	5.62	6.28	5.63	4.63	5.09	6.49	6.84
Price/Free Cash Flow Low	2.62	2.49	2.55	3.77	3.97	2.84	3.4	3.81	4.37	3.46	3.54	3.26	3.61	4.1	4.7
EV/Sales Average	1.65	1.5	1.68	2.05	2.04	1.66	1.62	1.9	1.92	2.58	2.49	2	2.05	2.24	2.48
EV/Sales High	1.9	1.62	1.9	2.23	2.19	1.75	1.72	2.2	2.07	2.96	2.73	2.18	2.23	2.58	2.75
EV/Sales Low	1.35	1.32	1.42	1.86	1.83	1.5	1.49	1.59	1.79	2.1	2.08	1.77	1.79	1.86	2.07
EV/EBITDA Average	7.32	6.44	6.84	8.51	9.18	7.38	7.61	9.24	9.68	12.54	11.39	9.93	9.79	10.35	10.66
EV/EBITDA High	8.41	6.98	7.73	9.24	9.85	7.77	8.09	10.67	10.44	14.4	12.49	10.83	10.62	11.9	11.83
EV/EBITDA Low	5.98	5.7	5.77	7.72	8.23	6.64	7	7.73	9.06	10.22	9.5	8.82	8.55	8.59	8.91
EV/EBIT Average	8.86	7.72	8.25	10.48	11.5	9.35	9.76	11.95	12.74	17.34	15.18	13.77	13.45	13.94	13.98
EV/EBIT High	10.19	8.38	9.32	11.37	12.34	9.83	10.38	13.8	13.74	19.91	16.65	15.02	14.6	16.03	15.52
EV/EBIT Low	7.24	6.84	6.96	9.51	10.31	8.4	8.99	10	11.92	14.13	12.67	12.23	11.76	11.57	11.69
Last Price	14.05	16.78	26.49	30.58	27.68	32.79	39.29	49.06	55.08	65.75	51.89	59.81	66.72	92.35	106.14
High Price	22.66	19.87	29.43	33.72	38.46	34.49	40.08	65.56	57.99	69.26	71.3	59.91	72.06	104.55	127.99
Enterprise Value Average	3,313	3,192	3,784	4,878	6,371	6,065	6,339	8,144	8,822	9,195	10,008	8,677	9,845	12,048	14,726
Enterprise Value High	3,811	3,462	4,277	5,296	6,837	6,380	6,743	9,406	9,516	10,562	10,979	9,465	10,683	13,855	16,342
Enterprise Value Low	2,709	2,828	3,192	4,427	5,713	5,451	5,837	6,814	8,253	7,496	8,352	7,704	8,603	10,003	12,308

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	95	96	88	88	90	89	98	99	99	99	99	100	100	101	100
Diluted Weighted Avg Shares	109	108	102	101	101	100	99	100	99	100	100	100	101	102	102
Basic Weighted Avg Shares	93	95	88	87	89	89	94	98	98	99	99	99	100	100	100
Revenue per Share	21.5	22.57	25.51	27.35	34.85	40.88	41.77	43.69	46.99	36.17	40.55	43.84	48.25	53.79	59.06
EBITDA per Share	4.85	5.24	6.28	6.61	7.76	9.22	8.89	9	9.3	7.44	8.88	8.81	10.11	11.65	13.74
Operating Income per Share	4.01	4.37	5.21	5.37	6.2	7.28	6.93	6.96	7.07	5.38	6.66	6.35	7.35	8.65	10.48
Basic EPS, GAAP	1.96	1.7	3.43	2.49	2.03	2.78	2.89	2.99	3.66	2.88	4.16	2.73	3.54	4.56	5.63
Basic EPS from Cont Ops	2.21	2.45	4.34	3.18	2.84	3.57	3.74	3.82	4.56	2.82	4.07	3.54	4.77	6	7.56
Diluted EPS, GAAP	1.67	1.49	2.96	2.14	1.8	2.49	2.73	2.93	3.61	2.85	4.11	2.7	3.47	4.46	5.54
Diluted EPS from Cont Ops	1.88	2.14	3.75	2.74	2.51	3.2	3.53	3.75	4.49	2.79	4.02	3.49	4.69	5.86	7.44
Dividend per Share	0.28	0.26	0.44	0.83	0.86	0.94	0.98	1.03	1.11	1.13	1.13	1	0.61	0.63	0.71
Cash Flow per Share	3.67	4.35	5.34	5.13	5.62	7.19	7.03	7.79	6.48	7.15	7.23	7.11	8.55	10.04	11.7
Free Cash Flow per Basic Share	2.5	2.66	2.88	2.96	3.86	4.91	4.58	5.13	2.49	3.13	1.65	1.12	2.69	3.61	4.37
Cash & Equivalents per Share	0.48	1.4	0.73	0.77	0.69	0.45	0.58	0.71	0.97	2.27	0.5	0.22	0.69	0.85	0.72
Book Value per Share	-27.96	-25.62	-23.84	-21.64	-18.96	-16.24	-12.54	-9.03	-5.36	-2.45	1.44	1.18	4.1	7.99	12.84
Tangible Book Value per Share	-2.98	-1.05	-0.71	-7.9	-15.76	-14.27	-8.1	-7.41	-8.66	-7.59	10.14	3.19	7.41	12.68	16.42

Encompass Health Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)